We’re Grateful to Be Recognized in GEN: Genetic Engineering & Biotechnology News

As a startup, every milestone feels especially meaningful—and today we’re feeling deeply grateful.

We’re proud to share that Neoclease has been featured in GEN: Genetic Engineering & Biotechnology News, one of the leading publications in our field. This recognition helps amplify our mission to redefine what’s possible in precision gene editing and bring more awareness to the work we’re doing to tackle complex challenges in human health.

To be highlighted alongside so many innovators in the biotechnology and AI space reminds us why we do what we do—and how fortunate we are to have a team so dedicated to shaping the future of therapeutics.

We’re just getting started, and we’re excited for what’s ahead.

Read the full article here: AI-Enabled Gene Editing Produces Fewer Off-Target Outcomes

Thank you to our incredible team, partners, and supporters who make this journey possible.